J. M. Wilmink

1.5k citations

50 papers · 1.2k indexed · h-index 19

Co-authors: Ineke J. M. ten Berge Adam Tegzess L. Abraham‐Inpijn José Brás C.P. van Ooij Leo P. de Waal Janto Surachno S. Surachno
Topics: Renal Transplantation Outcomes and Treatments (13 papers)Blood groups and transfusion (7 papers)Metabolism and Genetic Disorders (5 papers)
Cited by: Transplantation Oral Surgery Complementary and Manual Therapy
Journals: New England Journal of Medicine The Lancet Journal of Clinical Investigation
Partner nations: Netherlands France

In The Last Decade

J. M. Wilmink

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by J. M. Wilmink

Since Specialization

Citations

This map shows the geographic impact of J. M. Wilmink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Wilmink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Wilmink more than expected).

Fields of papers citing papers by J. M. Wilmink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Wilmink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Wilmink. The network helps show where J. M. Wilmink may publish in the future.

Co-authorship network of co-authors of J. M. Wilmink

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Wilmink. A scholar is included among the top collaborators of J. M. Wilmink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Wilmink. J. M. Wilmink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conditional survival after resection of pancreatic cancer: A population-based study 2020 ·HPB ·(unknown),Lydia G. van der Geest,R. Michael van Dam,Bas Groot Koerkamp,Ignace H. J. T. de Hingh,Marjolein Y.V. Homs,J.M. Klaase,(unknown),V.E.P.P. Lemmens,I. Quintus Molenaar,Manfred Stommel,O.R. Busch,(unknown),Hanneke W.M. van Laarhoven,J. M. Wilmink,Marc G. Besselink	1
2	Measurements of 99mTc-MAG3 Uptake in Renal Transplant Recipients 2015 ·Contributions to nephrology ·H.Y. Oei,S. Surachno,J. M. Wilmink,J. B. van der Schoot	1
3	Immune responsiveness in renal transplant recipients: Mycophenolic acid severely depresses humoral immunity in vivo 2002 ·Kidney International ·Rob J. Rentenaar,Frank N.J. van Diepen,(unknown),S. Surachno,J. M. Wilmink,Peter Th.A. Schellekens,Steven T. Pals,René A. W. van Lier,Ineke J. M. ten Berge	67
4	A man with a Hippocratic syndrome? 1998 ·The Lancet ·Ilse Mombaerts,J. M. Wilmink,Roel Goldschmeding,Leo Koornneef	0
5	Long‐term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion 1998 ·British Journal of Haematology ·(unknown),(unknown),Ester B. M. Remmerswaal,Ineke J. M. ten Berge,J. M. Wilmink,Leo P. de Waal,Claire J. P. Boog	18
6	INFLUENCE OF HLA-DRB1* INCOMPATIBILITY ON THE OCCURRENCE OF REJECTION EPISODES AND GRAFT SURVIVAL IN SEROLOGICALLY HLA-DR-MATCHED RENAL TRANSPLANT COMBINATIONS1 1997 ·Transplantation ·Neubury M. Lardy,A. R. van der Horst,Ineke J. M. ten Berge,S. Surachno,J. M. Wilmink,Leo P. de Waal	9
7	Can Low-Calcium Peritoneal Dialysis Solution Safely Replace the Standard Calcium Solution in the Majority of Chronic Peritoneal Dialysis Patients? 1996 ·Peritoneal Dialysis International ·(unknown),Dirk G. Struijk,Henk J. Huijgen,E. W. Boeschoten,J. M. Wilmink	9
8	COMPARISON OF T CELL RESPONSES IN PATIENTS WITH A LONG-TERM SURVIVING RENAL ALLOGRAFT VERSUS A LONG-TERM SURVIVING LIVER ALLOGRAFT 1996 ·Transplantation ·E. van Twuyver,(unknown),R.J.M. ten Berge,J. M. Wilmink,(unknown),(unknown),M. J. H. Slooff,Leo P. de Waal	21
9	HIGH-AFFINITY CYTOTOXIC T LYMPHOCYTES AFTER NON-HLA-SHARING BLOOD TRANSFUSION—THE OTHER SIDE OF THE COIN 1994 ·Transplantation ·E. van Twuyver,(unknown),Ineke J. M. ten Berge,A. R. van der Horst,J. M. Wilmink,Frans H.J. Claas,Leo P. de Waal	18
10	Low-dose OKT3 induction therapy following renal transplantation: a controlled study 1994 ·Nephrology Dialysis Transplantation ·(unknown),R.J.M. ten Berge,M. H. M. Raasveld,Janto Surachno,J. M. Wilmink,P.Th.A. Schellekens	15
11	Pretreatment with divided doses of steroids strongly decreases side effects of OKT3 1994 ·Kidney International ·Fréderike J. Bemelman,(unknown),Janto Surachno,J. M. Wilmink,Peter Th.A. Schellekens,(unknown)	14
12	Serum neopterin/creatinine values correlate with severity of symptoms caused by cytomegalovirus infection in renal transplant recipients 1993 ·Transplant International ·M. H. M. Raasveld,Elisabeth Bloemena,Pauline Wertheim‐van Dillen,Janto Surachno,J. M. Wilmink,Ineke J. M. ten Berge	6
13	Effect of Dietary Fish Oil on Renal Function and Rejection in Cyclosporine-Treated Recipients of Renal Transplants 1993 ·New England Journal of Medicine ·Jaap J. Homan van der Heide,Henk Bilo,(unknown),J. M. Wilmink,Adam Tegzess	153
14	Decrease of erythrocyte deformability in cyclosporine-treated renal transplant patients: correction with fish oil as well as corn oil 1992 ·PubMed ·(unknown),M. R. Hardeman,J. M. Wilmink	6
15	Dietary supplementation with fish oil modifies renal reserve filtration capacity in postoperative, cyclosporin A-treated renal transplant recipients 1990 ·Transplant International ·(unknown),H. J. G. Bilo,A. J. M. Donker,J. M. Wilmink,Wim J. Sluiter,Adam Tegzess	15
16	ALLOGRAFT TOLERANCE INDUCTION IN ADULT MICE ASSOCIATED WITH FUNCTIONAL DELETION OF SPECIFIC CTL PRECURSORS 1989 ·Transplantation ·E. van Twuyver,W. Martin Kast,(unknown),J. M. Wilmink,Cornelis J.M. Melief,Leo P. de Waal	24
17	THE INFLUENCE OF IMMUNOSUPPRESSIVE TREATMENT ON IMMUNE RESPONSIVENESS IN VIVO IN KIDNEY TRANSPLANT RECIPIENTS 1989 ·Transplantation ·(unknown),Elisabeth Bloemena,(unknown),J. M. Wilmink,P.Th.A. Schellekens,Marinus H. J. van Oers	9
18	Anticoagulant effects of a low molecular weight heparinoid (ORG 10172) in human volunteers and haemodialysis patients 1985 ·Thrombosis Research ·Hugo Ten Cate,Ch. P. Henny,J W ten Cate,Harry R. Büller,(unknown),S. Surachno,J. M. Wilmink	18
19	USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONS 1983 ·The Lancet ·Ch. P. Henny,(unknown),H van Bronswijk,Hugo Ten Cate,S. Surachno,J. M. Wilmink,Paul Ockelford	47
20	The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients 1981 ·Clinical Immunology and Immunopathology ·R.J.M. ten Berge,P.Th.A. Schellekens,S. Surachno,T H Thé,J Veen,J. M. Wilmink	25

About J. M. Wilmink

J. M. Wilmink is a scholar working on Transplantation, Hematology and Clinical Biochemistry, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (13 papers), Blood groups and transfusion (7 papers) and Metabolism and Genetic Disorders (5 papers). The work is most often cited by research in Transplantation (229 citations), Oral Surgery (140 citations) and Complementary and Manual Therapy (32 citations). J. M. Wilmink has collaborated with scholars based in Netherlands and France. Frequent co-authors include Ineke J. M. ten Berge, Adam Tegzess, L. Abraham‐Inpijn, José Brás, C.P. van Ooij, Leo P. de Waal, Janto Surachno, S. Surachno, Henk Bilo and Jaap J. Homan van der Heide. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact